Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Ocular myasthenia gravis and risk factors for developing a secondary generalisation: description of a Spanish series
I. Díaz-Maroto; J. García-García; P.A. Sánchez-Ayaso; C. Alcahut-Rodríguez; E. González-Villar; J.M. Pardal-Fernández; T. Segura;
Neurologia. 2023;38:229-35
Embolic stroke of undetermined source: beyond atrial fibrillation
A. Arauz; C. Arteaga; C. Zapata-Gómez; C. Ramos-Ventura; B. Méndez; R. Otiniano-Sifuentes; S. Haseeb; R. González-Oscoy; A. Baranchuk;
Neurologia. 2022;37:362-70
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance
A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;
Neurologia. 2022;37:136-50